As cancer patients use AI chatbots, dangers lurk—but new safeguards can help

Share on facebook
Share on twitter
Share on linkedin
Share on email
Share on print

Patients affected by cancer are increasingly turning to artificial intelligence-powered chatbots, such as ChatGPT and Gemini, for answers to pressing health questions. These tools, available around the clock and free from geographic or scheduling constraints, are appealing when access to medical professionals is limited by financial, language, logistical, or emotional barriers. 

To access this subscriber-only content please log in or subscribe.

If your institution has a site license, log in with IP-login or register for a sponsored account.*
*Not all site licenses are enrolled in sponsored accounts.

Login Subscribe
Ghulam Rasool, PhD
Assistant member, Department of Machine Learning, H. Lee Moffitt Cancer Center & Research Institute
Brian D. Gonzalez, PhD
Associate center director for research career development, Associate member, Department of Health Outcomes & Behavior, H. Lee Moffitt Cancer Center & Research Institute
Katherine Chung-Bridges, MD, MPH
Chief community research officer, Health Choice Network
Table of Contents

YOU MAY BE INTERESTED IN

Ghulam Rasool, PhD
Assistant member, Department of Machine Learning, H. Lee Moffitt Cancer Center & Research Institute
Brian D. Gonzalez, PhD
Associate center director for research career development, Associate member, Department of Health Outcomes & Behavior, H. Lee Moffitt Cancer Center & Research Institute
Katherine Chung-Bridges, MD, MPH
Chief community research officer, Health Choice Network

Never miss an issue!

Get alerts for our award-winning coverage in your inbox.

Login